Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?

Anders Perner^*, Balasubramanian Venkatesh

^*Corresponding author af dette arbejde

Afdeling for Intensiv Behandling i Center for Kræft og Organsygdomme

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Lancet
Vol/bind	401
Udgave nummer	10387
Sider (fra-til)	1474-6
Antal sider	3
ISSN	0140-6736
DOI	https://doi.org/10.1016/S0140-6736(23)00587-1
Status	Udgivet - 6 maj 2023

Adgang til dokumentet

10.1016/S0140-6736(23)00587-1

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{463acf191dbe4de8ab38df5473021e2d,

title = "Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?",

author = "Anders Perner and Balasubramanian Venkatesh",

year = "2023",

month = may,

day = "6",

doi = "10.1016/S0140-6736(23)00587-1",

language = "English",

volume = "401",

pages = "1474--6",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "10387",

}

TY - JOUR

T1 - Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?

AU - Perner, Anders

AU - Venkatesh, Balasubramanian

PY - 2023/5/6

Y1 - 2023/5/6

UR - http://www.scopus.com/inward/record.url?scp=85153876790&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(23)00587-1

DO - 10.1016/S0140-6736(23)00587-1

M3 - Comment/debate

C2 - 37060914

SN - 0140-6736

VL - 401

SP - 1474

EP - 1476

JO - Lancet

JF - Lancet

IS - 10387

ER -